Clinical Efficacy Protocol of Yinhuapinggan Granules: A Randomized, Double-Blind, Parallel, and Controlled Clinical Trial Program for the Intervention of Community-Acquired Drug-Resistant Bacterial Pneumonia as a Complementary Therapy
Background: Community-acquired bacterial pneumonia (CABP) is an important health care concern in the worldwide, and is associated with significant morbidity, mortality, and health care expenditure. Streptococcus pneumoniae is the most frequent causative pathogen of CABP. Common treatment for hospita...
Saved in:
Main Authors: | Jiaoli Wang (Author), Haoran Hu (Author), Haixia Du (Author), Man Luo (Author), Yilan Cao (Author), Jiaping Xu (Author), Tianhang Chen (Author), Yilei Guo (Author), Qixiang Li (Author), Wen Chen (Author), Yifei Zhang (Author), Jin Han (Author), Haitong Wan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: Clinical efficacy protocol of yinhuapinggan granules: A randomized, double-blind, parallel, and controlled clinical trial program for the intervention of community-acquired drug-resistant bacterial pneumonia as a complementary therapy
by: Jiaoli Wang, et al.
Published: (2022) -
Preliminary study of Yinhuapinggan granule against H1N1 influenza virus infection in mice through inhibition of apoptosis
by: Hai-xia Du, et al.
Published: (2020) -
Spectrum effect correlation of yangyin tongnao granules on cerebral ischemia-reperfusion injury rats
by: Yangyang Zhang, et al.
Published: (2022) -
Danhong Injection Attenuates Cerebral Ischemia-Reperfusion Injury in Rats Through the Suppression of the Neuroinflammation
by: Haixia Du, et al.
Published: (2021) -
Guhong Injection Protects Against Apoptosis in Cerebral Ischemia by Maintaining Cerebral Microvasculature and Mitochondrial Integrity Through the PI3K/AKT Pathway
by: Huifen Zhou, et al.
Published: (2021)